Security key
75629V104
RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX)
CUSIP: 75629V104
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Class A Stock
- Shares outstanding
- 525,302,736
- Total 13F shares
- 264,392,743
- Share change
- +9,331,280
- Total reported value
- $1,743,289,324
- Put/Call ratio
- 172%
- Price per share
- $6.59
- Number of holders
- 262
- Value change
- +$54,064,157
- Number of buys
- 150
- Number of sells
- 95
Report period
Q3 2024
Institutions
262
Top holders
10
RXRX full security history
Newer quarter: Q4 2024
Previous quarter: Q2 2024
RECURSION PHARMACEUTICALS, INC. SEC filings
RECURSION PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 75629V104
Recent filing periods:
Top shareholders of RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
28%
|
143,085,126
|
$47,833,358 | — | 30 Jun 2024 | |
| Anchorage Capital Group, L.L.C. |
13F
|
Company |
13%
|
69,854,593
|
$23,352,390 | — | 30 Jun 2024 | |
| GLENVIEW CAPITAL MANAGEMENT, LLC |
13F
|
Company |
5.1%
|
26,500,000
|
$8,858,950 | — | 30 Jun 2024 | |
| SB INVESTMENT ADVISERS (UK) LTD |
13F
|
Company |
4.7%
|
24,429,191
|
$8,166,679 | — | 30 Jun 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
3.4%
|
17,356,369
|
$5,802,234 | — | 30 Jun 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
3%
|
15,512,302
|
$5,185,762 | — | 30 Jun 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
2.9%
|
15,384,615
|
$115,384,613 | — | 30 Jun 2024 | |
| Mubadala Investment Co PJSC |
3/4/5
13F
|
10%+ Owner · Company |
2.5%
from 13F
|
12,985,927
|
$137,333,970 | — | 02 Mar 2023 | |
| Kinnevik AB (publ) |
13F
|
Company |
2.3%
|
11,905,668
|
$89,292,510 | — | 30 Jun 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
2%
|
10,363,108
|
$3,390,809 | — | 30 Jun 2024 | |
| Monaco Asset Management SAM |
13F
|
Company |
1.9%
|
9,800,000
|
$3,276,140 | — | 30 Jun 2024 | |
| MIC Capital Management UK LLP |
13F
|
Company |
1.6%
|
8,451,758
|
$63,388,186 | — | 30 Jun 2024 | |
| NVIDIA CORP |
13F
|
Company |
1.5%
|
7,706,363
|
$57,797,723 | — | 30 Jun 2024 | |
| WELCH & FORBES LLC |
13F
|
Company |
1.4%
|
7,270,000
|
$2,243,522 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.2%
|
6,366,901
|
$2,128,455 | — | 30 Jun 2024 | |
| Data Collective IV GP, LLC |
13F
|
Company |
1.1%
|
5,941,120
|
$44,558,400 | — | 30 Jun 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.92%
|
4,779,497
|
$1,597,000 | — | 30 Jun 2024 | |
| a16z Capital Management, L.L.C. |
13F
|
Company |
0.84%
|
4,342,749
|
$1,451,781 | — | 30 Jun 2024 | |
| DCVC Opportunity Fund II GP, LLC |
13F
|
Company |
0.75%
|
3,951,141
|
$29,633,558 | — | 30 Jun 2024 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.72%
|
3,731,709
|
$1,299,381 | — | 30 Jun 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.54%
|
2,795,488
|
$935,000 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.42%
|
2,179,904
|
$728,742 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.37%
|
1,920,177
|
$14,402,075 | — | 30 Jun 2024 | |
| Establishment Unisphere |
13F
|
Individual |
0.35%
|
1,830,004
|
$602,986 | — | 30 Jun 2024 | |
| Gotham Asset Management, LLC |
13F
|
Company |
0.31%
|
1,622,406
|
$542,370 | — | 30 Jun 2024 | |
| Casdin Capital, LLC |
13F
|
Company |
0.28%
|
1,459,747
|
$487,993 | — | 30 Jun 2024 | |
| METEORA CAPITAL, LLC |
13F
|
Company |
0.25%
|
1,300,200
|
$434,657 | — | 30 Jun 2024 | |
| LUMINUS MANAGEMENT LLC |
13F
|
Company |
0.24%
|
1,250,000
|
$417,875 | — | 30 Jun 2024 | |
| Ghisallo Capital Management LLC |
13F
|
Company |
0.21%
|
1,100,000
|
$8,250,000 | — | 30 Jun 2024 | |
| Y-Intercept (Hong Kong) Ltd |
13F
|
Company |
0.2%
|
1,011,530
|
$338,154 | — | 30 Jun 2024 | |
| Alta Fundamental Advisers LLC |
13F
|
Company |
0.19%
|
1,000,000
|
$334,300 | — | 30 Jun 2024 | |
| Liontrust Investment Partners LLP |
13F
|
Company |
0.19%
|
990,000
|
$7,425,000 | — | 30 Jun 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.18%
|
933,898
|
$312,202 | — | 30 Jun 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.15%
|
769,230
|
$5,769,225 | — | 30 Jun 2024 | |
| Centiva Capital, LP |
13F
|
Company |
0.15%
|
754,455
|
$252,214 | — | 30 Jun 2024 | |
| MACKENZIE FINANCIAL CORP |
13F
|
Company |
0.14%
|
749,768
|
$250,647 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.14%
|
745,079
|
$5,588,093 | — | 30 Jun 2024 | |
| CAPSTONE INVESTMENT ADVISORS, LLC |
13F
|
Company |
0.14%
|
723,942
|
$242,014 | — | 30 Jun 2024 | |
| SVB WEALTH LLC |
13F
|
Company |
0.13%
|
695,000
|
$232,339 | — | 30 Jun 2024 | |
| Cercano Management LLC |
13F
|
Company |
0.13%
|
685,018
|
$5,137,635 | — | 30 Jun 2024 | |
| EQUITEC PROPRIETARY MARKETS, LLC |
13F
|
Company |
0.13%
|
672,488
|
$224,813 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.13%
|
664,450
|
$4,983,375 | — | 30 Jun 2024 | |
| Coastal Bridge Advisors, LLC |
13F
|
Company |
0.13%
|
647,619
|
$216,499 | — | 30 Jun 2024 | |
| Polymer Capital Management (HK) LTD |
13F
|
Company |
0.12%
|
624,000
|
$208,603 | — | 30 Jun 2024 | |
| Boston Standard Wealth Management, LLC |
13F
|
Company |
0.12%
|
606,634
|
$203,000 | — | 30 Jun 2024 | |
| CANADA LIFE ASSURANCE Co |
13F
|
Company |
0.11%
|
589,561
|
$194,000 | — | 30 Jun 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.11%
|
577,962
|
$193,211 | — | 30 Jun 2024 | |
| Institute for Wealth Management, LLC. |
13F
|
Company |
0.11%
|
580,997
|
$4,357,478 | — | 30 Jun 2024 | |
| Brevan Howard Capital Management LP |
13F
|
Company |
0.11%
|
552,576
|
$184,727 | — | 30 Jun 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.1%
|
521,854
|
$174,456 | — | 30 Jun 2024 |
Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX) as of Q3 2024
As of 30 Sep 2024,
RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX) was held by
262 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
264,392,743 shares.
The largest 10 holders included
ARK Investment Management LLC, BAILLIE GIFFORD & CO, VANGUARD GROUP INC, BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P., Mubadala Investment Co PJSC, STATE STREET CORP, Kinnevik AB (publ), Sumitomo Mitsui Trust Group, Inc., and Nikko Asset Management Americas, Inc..
This page lists
264
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
264
Q3 2024 holders
262
Holder diff
-2
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.